ロード中...

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study

BACKGROUND: Immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have been recently approved for treatment of patients with metastatic melanoma and non-small cell lung cancer (NSCLC). Despite important clinical benefit...

詳細記述

保存先:
書誌詳細
出版年:J Immunother Cancer
主要な著者: Koelzer, Viktor H., Rothschild, Sacha I., Zihler, Deborah, Wicki, Andreas, Willi, Berenika, Willi, Niels, Voegeli, Michèle, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791920/
https://ncbi.nlm.nih.gov/pubmed/26981243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0117-1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!